4.7 Article

RNA-seq based elucidation of mechanism underlying the protective effect of Huangshui polysaccharide on intestinal barrier injury in Caco-2 cells

Journal

FOOD RESEARCH INTERNATIONAL
Volume 162, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.foodres.2022.112175

Keywords

Huangshui; Polysaccharides; Componential analysis; Intestinal barrier; RNA-seq; TRL4/MyD88/NF-kappa B; MAPK signaling pathway

Funding

  1. National Natural Science Foundation of China [31901815, 31701567]
  2. School Level Cultivation Foundation of Beijing Technology and Business University for Distinguished and Excellent Young Scholars [BTBUYP2021, 19008021164]

Ask authors/readers for more resources

NLS-2 polysaccharide protects the intestinal barrier by inhibiting inflammatory cytokines and increasing tight junction protein expression, thus reducing intestinal permeability. This effect may be achieved by inhibiting the MAPK and NF-kappa B signaling pathways.
Polysaccharides from Huangshui (HS) have the function of antioxidant and immunoregulation, but its intestinal barrier protection activity and the underlying mechanism remains unclear. The present work mainly studied the intestinal barrier protection function and its potential molecular mechanism of a heteropolysaccharide named NLS-2 with a molecular weight of 51.9 kDa. NLS-2 reduced intestinal permeability by decreasing the content of inflammatory cytokines and increasing the expression of tight junction (TJ) protein in LPS-damaged Caco-2 cells, thus protecting the intestinal barrier function. RNA-seq results showed that the differentially expressed genes (DEGs) were mainly enriched in the signaling pathways of MAPK, Toll-like receptor, and NF-kappa B. Subsequent western blot validation experiments proved that NLS-2 could indeed inhibit the two pathways of MAPK and NF-kappa B by reducing the expression of TRL4, thereby down-regulating the release of downstream pro-inflammatory cytokines and playing the role of intestinal barrier protection. Collectively, NLS-2 has beneficial effects on LPS-damaged intestinal barrier by inhibiting the TRL4/MyD88/NF-kappa B and MAPK signaling pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available